GLMD earnings date and last-quarter result: next report 2026-07-30, last quarter beat, P/E -0.25. Updated 2026-07-23.
Galmed Pharmaceuticals (GLMD) Research Hub
Galmed Pharmaceuticals (GLMD) trades on NASDAQ, IL in the Healthcare (Biotechnology) sector. As of 2026-10-01, shares last closed at 3.41 USD (-26.35%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.25, market cap 0.00B. This hub links to the full technical, earnings and options research available for GLMD.
Last updated 2026-10-01 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 3.41 USD (-26.35%) |
| 52-week range | 3.12 USD – 5.45 USD |
| Trend regime | Range |
| 14-day RSI | 33.9 (Bearish) |
| Trailing P/E | -0.25 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for GLMD
Covered Call on GLMD: how it works, illustrative setup around the real 3.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GLMD: how it works, illustrative setup around the real 3.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GLMD: how it works, illustrative setup around the real 3.41 USD price, max profit/loss, breakeven and when to use it. Educational.
GLMD technical analysis: range, last 3.41 USD, RSI 33.9, 52w range 3.12 USD–5.45 USD, real support/resistance. Updated 2026-10-01.
More on SniperIQ
Frequently asked questions
What sector is GLMD in?
Galmed Pharmaceuticals (GLMD) is classified under Healthcare (Biotechnology), listed on NASDAQ, IL.
Is GLMD in an uptrend or downtrend?
As of 2026-10-01, GLMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GLMD's trailing P/E ratio?
GLMD's trailing P/E is -0.25, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does GLMD next report earnings?
GLMD is next scheduled to report earnings on 2026-07-30.